Bailard Inc. lowered its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 1.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 217,195 shares of the biopharmaceutical company’s stock after selling 4,219 shares during the period. Bailard Inc.’s holdings in Pfizer were […]
Bailard Inc. lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 217,195 shares of the biopharmaceutical company’s stock after selling 4,219 shares during the quarter. Bailard Inc.’s […]
Capital Advisors Ltd. LLC lifted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 7.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 14,836 shares of the biopharmaceutical company’s stock after acquiring an additional 978 shares during the quarter. Capital Advisors Ltd. LLC’s […]
Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Cutter & CO Brokerage Inc. lifted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the quarter. Cutter & […]